The concentration of transferrin in CSF reflects brain iron availability and can serve as a biomarker in different diseases [25] such as arterial hypertension, which has effects on the secretory capacity of the CP, resulting in lower transferrin levels in the CSF of the SHR with respect to WKY. This evidence concerns the gene CP and Hypertension.